Skip to main content

RT @RichardPAConway: Proft @ProftDr et al. NSAIDs+golimumab no better than golimumab monotherapy in reducing spinal prog

Social Author Name
Richard Conway
Tweet Content
Proft @ProftDr et al. NSAIDs+golimumab no better than golimumab monotherapy in reducing spinal progression in AS. But... for high risk patients there may be some benefit - see figure. @RheumNow #ACR22 Abstr#0546 https://t.co/xo9Uy6aX71 https://t.co/vZgaoeEQn4
Show on Archive Page
On
Display in Search Results
On
PDQ
Off